Newtyn Management LLC lowered its holdings in Cannae Holdings, Inc. (NYSE:CNNE - Free Report) by 3.0% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,169,631 shares of the company's stock after selling 97,324 shares during the period. Cannae comprises about 5.8% of Newtyn Management LLC's investment portfolio, making the stock its 4th biggest holding. Newtyn Management LLC owned about 7.31% of Cannae worth $45,643,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in shares of Cannae during the 2nd quarter worth approximately $59,496,000. Almitas Capital LLC acquired a new position in Cannae during the 2nd quarter valued at approximately $10,675,000. Rubric Capital Management LP grew its stake in Cannae by 41.3% during the 2nd quarter. Rubric Capital Management LP now owns 2,105,864 shares of the company's stock worth $43,907,000 after buying an additional 615,616 shares during the last quarter. State of Wisconsin Investment Board grew its stake in Cannae by 109.6% during the 4th quarter. State of Wisconsin Investment Board now owns 815,918 shares of the company's stock worth $12,834,000 after buying an additional 426,736 shares during the last quarter. Finally, Jane Street Group LLC grew its stake in Cannae by 467.8% during the 4th quarter. Jane Street Group LLC now owns 468,356 shares of the company's stock worth $7,367,000 after buying an additional 385,865 shares during the last quarter. 88.12% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of research firms have issued reports on CNNE. Weiss Ratings upgraded Cannae from a "sell (d-)" rating to a "sell (d)" rating in a research note on Wednesday. Wall Street Zen upgraded shares of Cannae from a "sell" rating to a "hold" rating in a research report on Saturday, August 15th. Finally, Royal Bank Of Canada reissued an "outperform" rating and set a $16.00 target price on shares of Cannae in a research note on Tuesday, August 11th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $16.50.
Check Out Our Latest Report on Cannae
Cannae Stock Performance
Shares of NYSE CNNE opened at $15.64 on Monday. The stock has a fifty day moving average price of $14.79 and a two-hundred day moving average price of $13.59. Cannae Holdings, Inc. has a 1 year low of $10.46 and a 1 year high of $19.88. The firm has a market cap of $678.31 million, a P/E ratio of -5.18 and a beta of 1.20. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.24 and a current ratio of 1.24.
Cannae (NYSE:CNNE - Get Free Report) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of ($0.42) by $1.28. Cannae had a negative net margin of 38.18% and a negative return on equity of 14.10%. The firm had revenue of $102.20 million for the quarter, compared to analysts' expectations of $99.65 million.
Cannae Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.8%. Cannae's payout ratio is -19.87%.
Cannae Company Profile
(
Free Report)
Cannae Holdings, Inc NYSE: CNNE is a publicly traded diversified holding company that focuses on partnering with and investing in businesses across a range of industry sectors. The company seeks to identify attractive opportunities in both private and public markets, leveraging its capital resources and management expertise to support operational growth and value creation. Cannae's investment strategy emphasizes companies in data and analytics, marketing services, healthcare technology, and payment processing.
Through its portfolio, Cannae holds controlling or significant minority stakes in companies that provide critical software, data and services to corporate clients.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cannae, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cannae wasn't on the list.
While Cannae currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.